NM_054027.6:c.97-45583T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_054027.6(ANKH):c.97-45583T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.27 in 152,106 control chromosomes in the GnomAD database, including 5,743 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.27 ( 5743 hom., cov: 32)
Consequence
ANKH
NM_054027.6 intron
NM_054027.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.106
Publications
8 publications found
Genes affected
ANKH (HGNC:15492): (ANKH inorganic pyrophosphate transport regulator) This gene encodes a multipass transmembrane protein that is expressed in joints and other tissues and controls pyrophosphate levels in cultured cells. Progressive ankylosis-mediated control of pyrophosphate levels has been suggested as a possible mechanism regulating tissue calcification and susceptibility to arthritis in higher animals. Mutations in this gene have been associated with autosomal dominant craniometaphyseal dysplasia. [provided by RefSeq, Jul 2008]
ANKH Gene-Disease associations (from GenCC):
- chondrocalcinosis 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- craniometaphyseal dysplasia, autosomal dominantInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- skeletal dysplasiaInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- craniometaphyseal dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.34 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.270 AC: 41095AN: 151988Hom.: 5736 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
41095
AN:
151988
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.270 AC: 41128AN: 152106Hom.: 5743 Cov.: 32 AF XY: 0.269 AC XY: 19968AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
41128
AN:
152106
Hom.:
Cov.:
32
AF XY:
AC XY:
19968
AN XY:
74352
show subpopulations
African (AFR)
AF:
AC:
8684
AN:
41492
American (AMR)
AF:
AC:
5321
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
1131
AN:
3468
East Asian (EAS)
AF:
AC:
1598
AN:
5182
South Asian (SAS)
AF:
AC:
1111
AN:
4826
European-Finnish (FIN)
AF:
AC:
2856
AN:
10562
Middle Eastern (MID)
AF:
AC:
59
AN:
294
European-Non Finnish (NFE)
AF:
AC:
19515
AN:
67978
Other (OTH)
AF:
AC:
517
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1549
3098
4647
6196
7745
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
915
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.